The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Ranibizumab for Diabetic Macular Edema
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Early Photocoagulation for Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38011-7 · Cited by 1,259
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196 · cited 1×
“S c c 5 p r e Diabetic retinopathy (DR), the most common microvascular complication of diabetes,(1) is the leading cause of new cases of vision loss and blindness among workingaged adults in the United States and most developed countries.(2,3) Diabetic macular edema (DME), swelling of the central retina that causes vi…”
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Self-citationIntravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Fong, D. S., Aiello, L. P., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2540 · Cited by 640
Elman, M. J., Bressler, N. M., Qin, H., Beck, R. W., Ferris, F. L., Friedman, S. M., Glassman, A. R., Scott, I. U., Stockdale, C. R., & Sun, J. K. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.033 · Cited by 573
Early breakdown of the blood-retinal barrier in diabetes.
Cunha-Vaz, J., Faria de Abreu, J. R., & Campos, A. J. (1975) · British Journal of Ophthalmology · doi:10.1136/bjo.59.11.649 · Cited by 562
(2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.015 · Cited by 548
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.016 · Cited by 532
Self-citationMichaelides, M., Kaines, A., Hamilton, R. D., Fraser-Bell, S., Rajendram, R., Quhill, F., Boos, C. J., Xing, W., Egan, C., Peto, T., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.045 · Cited by 521
Tolentino, M. J., Miller, J. W., Gragoudas, E. S., Jakobiec, F. A., Flynn, E., Chatzstefanou, K., Ferrara, N., & Adamis, A. P. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30420-x · Cited by 518
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum, T., Xu, Q., Joussen, A. M., Clemens, M. W., Qin, W., Miyamoto, K., Hasséssian, H., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., et al. (2001) · PubMed · Cited by 508
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
(2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.062 · Cited by 451
Campochiaro, P. A., Brown, D. M., Pearson, A., Ciulla, T., Boyer, D., Holz, F. G., Tolentino, M., Gupta, A., Duarte, L., Madreperla, S., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.028 · Cited by 405
Self-citationJavitt, J. C., Aiello, L. P., Chiang, Y., Ferris, F. L., Canner, J. K., & Greenfield, S. (1994) · Diabetes Care · doi:10.2337/diacare.17.8.909 · Cited by 364
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema
Nguyen, Q. D., Tatlipinar, S., Shah, S. M., Haller, J. A., Quinlan, E., Sung, J., Zimmer-Galler, I., Do, D. V., & Campochiaro, P. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.068 · Cited by 351
Self-citationNguyen, Q. D., Shah, S. M., Heier, J. S., Do, D. V., Lim, J., Boyer, D., Abraham, P., & Campochiaro, P. A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.023 · Cited by 340
Self-citationLong-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
Ip, M. S. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2012.1043 · Cited by 248
Etiology and Treatment of Macular Edema
Johnson, M. W. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.07.024 · Cited by 192
Visual acuity as an outcome measure in clinical trials of retinal diseases
Beck, R. W., Maguire, M. G., Bressler, N. M., Glassman, A. R., Lindblad, A. S., & Ferris, F. L. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.06.047 · Cited by 188
Dynamic balanced randomization for clinical trials
Signorini, D. F., Leung, O. K., Simes, R. J., Beller, E., Gebski, V., & Callaghan, T. (1993) · Statistics in Medicine · doi:10.1002/sim.4780122410 · Cited by 141
Screening for Presence or Absence of Diabetic Retinopathy: A Meta-analysis
Bragge, P. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.319 · Cited by 134
Clinically Significant Macular Edema and Survival in Type 1 and Type 2 Diabetes
Hirai, F. E., Knudtson, M. D., Klein, R., & Klein, R. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.11.019 · Cited by 76
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“Recombinant monoclonal neutralizing antibody to VEGF is a newly approved therapy that improves vision and reduces the need for laser photocoagulation in patients with macular edema (372).”
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Boyer, D. S., Yoon, Y. H., Belfort, R., Bandello, F., Maturi, R. K., Augustin, A. J., Li, X.-Y., Cui, H., Hashad, Y., & Whitcup, S. M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.024 · Cited by 1,122
Self-citation
Metadata
- Authors
- Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J., Rubio, R. G., & Ehrlich, J. S.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 119
- Issue
- 4
- Pages
- 789-801
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2616361514
- Cited by
- 1,621
- References
- 32
- FWCI
- 90.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.